Yifeng Pharmacy
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to… Read more
Yifeng Pharmacy (603939) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.055x
Based on the latest financial reports, Yifeng Pharmacy (603939) has a cash flow conversion efficiency ratio of 0.055x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥641.93 Million) by net assets (CN¥11.66 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Yifeng Pharmacy - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Yifeng Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Yifeng Pharmacy Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yifeng Pharmacy ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bandhan Bank Limited
NSE:BANDHANBNK
|
-0.063x |
|
Park Hotels & Resorts Inc
NYSE:PK
|
0.034x |
|
Meta Financial Group Inc
NASDAQ:CASH
|
0.127x |
|
Advanced Technology & Materials Co Ltd
SHE:000969
|
0.046x |
|
Danieli & C RSP
LSE:0N4I
|
0.099x |
|
Hyundai Autoever Corp
KO:307950
|
0.082x |
|
ITC HOTELS LIMITED
NSE:ITCHOTELS
|
N/A |
|
RBL Bank Limited
NSE:RBLBANK
|
0.037x |
Annual Cash Flow Conversion Efficiency for Yifeng Pharmacy (2011–2024)
The table below shows the annual cash flow conversion efficiency of Yifeng Pharmacy from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥11.39 Billion | CN¥4.22 Billion | 0.370x | -17.00% |
| 2023-12-31 | CN¥10.45 Billion | CN¥4.66 Billion | 0.446x | +3.86% |
| 2022-12-31 | CN¥9.12 Billion | CN¥3.92 Billion | 0.430x | +57.21% |
| 2021-12-31 | CN¥7.86 Billion | CN¥2.15 Billion | 0.273x | +18.34% |
| 2020-12-31 | CN¥5.78 Billion | CN¥1.34 Billion | 0.231x | +12.93% |
| 2019-12-31 | CN¥4.71 Billion | CN¥963.23 Million | 0.205x | +67.01% |
| 2018-12-31 | CN¥4.17 Billion | CN¥510.71 Million | 0.122x | +22.77% |
| 2017-12-31 | CN¥3.18 Billion | CN¥317.20 Million | 0.100x | +112.11% |
| 2016-12-31 | CN¥2.98 Billion | CN¥139.94 Million | 0.047x | -63.22% |
| 2015-12-31 | CN¥1.42 Billion | CN¥181.52 Million | 0.128x | -64.12% |
| 2014-12-31 | CN¥595.76 Million | CN¥212.35 Million | 0.356x | +14.22% |
| 2013-12-31 | CN¥502.20 Million | CN¥156.71 Million | 0.312x | +64.60% |
| 2012-12-31 | CN¥425.82 Million | CN¥80.73 Million | 0.190x | -45.08% |
| 2011-12-31 | CN¥356.28 Million | CN¥122.99 Million | 0.345x | -- |